Arsenic poisoning

Arsenic poisoning

HMBP Exam

HMBP Exam

Introduction to pharmacology

Light microscopy and staining methods

Cytoskeleton and intracellular motility

Pharmacodynamics: Agonist, partial agonist and antagonist

Cellular structure and function

Primary ciliary dyskinesia

Nuclear structure

Transcription of DNA

Translation of mRNA

DNA damage and repair

Amino acids and protein folding

Protein structure and synthesis

Myasthenia gravis

Human development days 1-4

Human development days 4-7

Human development week 2

Selective permeability of the cell membrane

Prions (Spongiform encephalopathy)

Ehlers-Danlos syndrome

Osteogenesis imperfecta

Cystic fibrosis

Diabetes mellitus

Beta-thalassemia

Inheritance patterns

Independent assortment of genes and linkage

Mitosis and meiosis

Gluconeogenesis

Essential fructosuria

Hereditary fructose intolerance

Amino acid metabolism

Arsenic poisoning

Patau syndrome (Trisomy 13)

Down syndrome (Trisomy 21)

Edwards syndrome (Trisomy 18)

Turner syndrome

Klinefelter syndrome

Angelman syndrome

Prader-Willi syndrome

Marfan syndrome

Citric acid cycle

Electron transport chain and oxidative phosphorylation

Pharmacokinetics: Drug metabolism

Pharmacokinetics: Drug elimination and clearance

Pentose phosphate pathway

Glycogen metabolism

Glycogen storage disease type I

Glycogen storage disease type II (NORD)

Glycogen storage disease type V

Glycogen storage disease type IV

Glycogen storage disease type III

Ketone body metabolism

Glucose-6-phosphate dehydrogenase (G6PD) deficiency

Cri du chat syndrome

Williams syndrome

Fatty acid synthesis

Fatty acid oxidation

Nucleotide metabolism

Antimetabolites for cancer treatment

Severe combined immunodeficiency

Lesch-Nyhan syndrome

Megaloblastic anemia

Hartnup disease

Cystinuria (NORD)

Drug administration and dosing regimens

Nitrogen and urea cycle

Cholesterol metabolism

Fragile X syndrome

Huntington disease

Friedreich ataxia

Polycystic kidney disease

Neurofibromatosis

Niemann-Pick disease types A and B (NORD)

Tay-Sachs disease (NORD)

Fabry disease (NORD)

Ornithine transcarbamylase deficiency

Maple syrup urine disease

Gaucher disease (NORD)

Niemann-Pick disease type C

Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)

Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)

Phenylketonuria (NORD)

Folate (Vitamin B9) deficiency

Vitamin B12 deficiency

Wernicke-Korsakoff syndrome

Zellweger spectrum disorders (NORD)

Vitamin C deficiency

Adenosine deaminase deficiency

Xeroderma pigmentosum

Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)

Gel electrophoresis and genetic testing

Fluorescence in situ hybridization

ELISA (Enzyme-linked immunosorbent assay)

Hardy-Weinberg equilibrium

Hemochromatosis

Alpha-thalassemia

Muscular dystrophy

Mitochondrial myopathy

Pharmacokinetics: Drug absorption and distribution

Pharmacodynamics: Drug-receptor interactions